BR112012022755A2 - composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos - Google Patents

composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos

Info

Publication number
BR112012022755A2
BR112012022755A2 BR112012022755A BR112012022755A BR112012022755A2 BR 112012022755 A2 BR112012022755 A2 BR 112012022755A2 BR 112012022755 A BR112012022755 A BR 112012022755A BR 112012022755 A BR112012022755 A BR 112012022755A BR 112012022755 A2 BR112012022755 A2 BR 112012022755A2
Authority
BR
Brazil
Prior art keywords
composition
treatment
probiotic bacteria
immune disorders
bacteria
Prior art date
Application number
BR112012022755A
Other languages
English (en)
Other versions
BR112012022755B1 (pt
Inventor
Gian Paolo Strozzi
Giovanni Mogna
Lorenzo Drago
Luca Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of BR112012022755A2 publication Critical patent/BR112012022755A2/pt
Publication of BR112012022755B1 publication Critical patent/BR112012022755B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/181—Salivarius
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Abstract

composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos. a presente invenção refere-se a uma composição que compreende bactérias para o tratamento de patologias associadas a alterações no sistema imunológico. mais especificamente, a presente invenção refere-se ao uso de bactérias probióticas selecionadas para preparar uma composição a fim de tratar alergias, tal como a dermatite atópica.
BR112012022755-6A 2010-03-08 2011-03-07 composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos BR112012022755B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A000375 2010-03-08
ITMI2010A000375A IT1398553B1 (it) 2010-03-08 2010-03-08 Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
PCT/IB2011/000490 WO2011110918A1 (en) 2010-03-08 2011-03-07 Composition comprising probiotic bacteria for use in the treatment of immune disorders

Publications (2)

Publication Number Publication Date
BR112012022755A2 true BR112012022755A2 (pt) 2016-07-19
BR112012022755B1 BR112012022755B1 (pt) 2021-03-02

Family

ID=42942117

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012022755-6A BR112012022755B1 (pt) 2010-03-08 2011-03-07 composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos

Country Status (18)

Country Link
US (3) US8734783B2 (pt)
EP (2) EP2544698B1 (pt)
JP (2) JP5931754B2 (pt)
KR (1) KR101872946B1 (pt)
CN (2) CN104800247A (pt)
AU (1) AU2011225798B2 (pt)
BR (1) BR112012022755B1 (pt)
CA (1) CA2792343C (pt)
DK (2) DK2544698T3 (pt)
ES (2) ES2581803T3 (pt)
HU (2) HUE029245T2 (pt)
IT (1) IT1398553B1 (pt)
PL (2) PL2544698T3 (pt)
PT (2) PT2626076T (pt)
RU (2) RU2712751C9 (pt)
UA (1) UA111715C2 (pt)
WO (1) WO2011110918A1 (pt)
ZA (2) ZA201207377B (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2011149335A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
ITMI20122270A1 (it) * 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
CA2899925A1 (en) 2013-02-04 2014-08-07 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
WO2014145958A2 (en) 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
FR3004349B1 (fr) * 2013-04-15 2015-11-27 Greentech Applications cosmetiques et pharmaceutiques de lactobacillus pentosus
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US10165788B2 (en) * 2013-06-17 2019-01-01 The Regents Of The University Of California Methods and compositions for improved digestion of milk oligosaccharides
MX367109B (es) 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CN108064132A (zh) 2014-10-31 2018-05-22 霍勒拜欧姆公司 与病症的微生物治疗和诊断有关的方法和组合物
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
RU2730005C2 (ru) * 2014-11-26 2020-08-14 Пробиотикал С.П.А Штаммы Lactobacillus или Bifidobacterium для поддержания гомеостаза
PT3193901T (pt) 2014-12-23 2018-06-29 4D Pharma Res Ltd Polipéptido de pirina e modulação imunitária
EP3065748B1 (en) 2014-12-23 2017-11-22 4D Pharma Research Limited A bacteroides thetaiotaomicron strain and its use in reducing inflammation
RU2720629C2 (ru) 2014-12-29 2020-05-12 Мофин С.Р.Л. Изготовление бездрожжевой легкоусвояемой пиццы с использованием теста, содержащего молочнокислые бактерии
HUE046770T2 (hu) * 2015-06-15 2020-03-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180267A1 (es) 2015-06-15 2018-02-06 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ES2753779T3 (es) 2015-06-15 2020-04-14 4D Pharma Res Ltd Blautia stercosis y wexlerae para la utilización en el tratamiento de enfermedades inflamatorias y autoinmunes
ITUB20155700A1 (it) * 2015-11-18 2017-05-18 Probiotical Spa Composizioni con azione sinergica tra un complesso gelificante muco-aderente contro il passaggio degli antigeni, e batteri immunomodulanti anti-IL17 per uso nel trattamento delle malattie autoimmuni e neurodegenerative IL17 dipendenti.
ITUB20155752A1 (it) 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ES2662617T3 (es) 2015-11-20 2018-04-09 4D Pharma Research Limited Composiciones que comprenden cepas bacterianas
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
JP6347268B2 (ja) * 2016-02-26 2018-06-27 トヨタ自動車株式会社 複合活物質の製造方法
AU2017226831B2 (en) 2016-03-04 2018-10-04 4D Pharma Plc Compositions comprising bacterial Blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
ITUA20164065A1 (it) * 2016-06-01 2017-12-01 Probiotical Spa Composizioni in gel per applicazioni topiche a base di batteri, preparazione delle stesse e loro usi.
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
TW201907929A (zh) 2017-05-22 2019-03-01 英商4D製藥研究有限公司 包含細菌品系之組成物
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
EP3638271B1 (en) 2017-06-14 2020-10-14 4D Pharma Research Limited Compositions comprising bacterial strains
KR102205829B1 (ko) 2017-06-14 2021-01-21 기초과학연구원 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체
TW201919668A (zh) 2017-06-14 2019-06-01 英商4D製藥研究有限公司 包含細菌品系之組成物
KR20200040277A (ko) 2017-08-14 2020-04-17 세레스 테라퓨틱스, 인코포레이티드 담즙정체성 질환 치료를 위한 조성물 및 방법
RU2699540C2 (ru) * 2017-08-17 2019-09-06 Павел Павлович Несмиянов Композиция, содержащая пробиотические бактерии или их компоненты, и способ ее применения в лечении иммунных заболеваний кожи
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
CN110710627A (zh) * 2018-07-12 2020-01-21 序瑞生物科技(上海)有限公司 一种功能性益生菌固体饮料及其制备方法
KR102130646B1 (ko) * 2018-10-15 2020-07-06 주식회사 제일바이오 신규한 락토바실러스 살리바리우스 및 이를 유효성분으로 포함하는 양식 어류 및 갑각류용 사료첨가제
CN113573721A (zh) * 2019-03-07 2021-10-29 波比奥泰克股份公司 优选用于儿科受试者的治疗过敏性哮喘和复发性喘鸣的益生菌菌株的混合物
CN110616167B (zh) * 2019-08-22 2022-02-01 江南大学 能够缓解特应性皮炎的双歧杆菌及其应用
CN110643541B (zh) * 2019-10-25 2021-08-24 江南大学 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
WO2021138599A1 (en) * 2020-01-03 2021-07-08 Forte Subsidiary, Inc. Cosmetic compositions
KR102152878B1 (ko) * 2020-03-02 2020-09-07 주식회사 잇츠한불 락토바실러스 펜토서스 균주 및 이를 포함하는 미생물 균총 개선 및 피부 장벽 개선용 조성물
CN111528479A (zh) * 2020-05-15 2020-08-14 深圳爱米基因科技有限责任公司 一种缓解特应性皮炎功能的益生菌和益生元组合物及应用
CN111700917B (zh) * 2020-06-18 2022-08-09 江南大学 一种用于预防和/或治疗特应性皮炎的产品
CN111840335A (zh) * 2020-07-07 2020-10-30 刘平祥 一种含有益生菌的组合物及其在气管炎哮喘上的应用
CN116546996A (zh) * 2020-07-31 2023-08-04 欣巴伦斯有限公司 用于调节免疫系统的益生菌组合物及其用途
IT202000018901A1 (it) * 2020-07-31 2022-01-31 Synbalance Srl Composizioni probiotiche e loro uso nella prevenzione e/o nel trattamento di patologie e/o disturbi della pelle
CN111944727B (zh) * 2020-08-24 2021-12-03 汤臣倍健股份有限公司 一种短双歧杆菌207-1及其应用
CN114304642A (zh) * 2021-11-25 2022-04-12 青岛康益生物科技有限公司 一种用于过敏的益生菌产品
CN115428954A (zh) * 2022-09-15 2022-12-06 北京三元食品股份有限公司 复合益生菌及发酵乳在制备用于辅助治疗hiv患者产品中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002341384A1 (en) * 2001-09-05 2003-03-24 Actial Farmaceutica, Lda. Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
FR2853908B1 (fr) * 2003-04-16 2005-06-03 Gervais Danone Sa Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
JP4740866B2 (ja) * 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物
ES2290762T3 (es) * 2004-08-05 2008-02-16 Anidral S.R.L. Cepas bacterianas de bifidobacterium que producen acido folico, sus formulaciones y utilizacion.
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
KR100479719B1 (ko) * 2005-01-29 2005-03-31 주식회사 프로바이오닉 유해 병원성 미생물 생육 억제능 및 항알레르기성을 갖는 신규 내산성 락토바실러스 사케이 Ｐｒｏｂｉｏ-65
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US9119414B2 (en) * 2007-12-07 2015-09-01 N.V. Nutricia Bifidobacterium for dust mite allergy
DK2213178T3 (da) 2009-01-28 2013-03-04 Metalquimia Sa Behandlingsenhed med tvungen konvektion til et kødprodukt skåret i skiver og en fremgangsmåde til behandling af et kødprodukt under anvendelse af førnævnte enhed
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
US20110064777A1 (en) * 2009-09-11 2011-03-17 Sharad Mohan Live lactobacillus soap and method for delivering lactobacillus to skin tissue
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.

Also Published As

Publication number Publication date
PT2626076T (pt) 2016-10-04
JP6182628B2 (ja) 2017-08-16
US9931363B2 (en) 2018-04-03
WO2011110918A8 (en) 2011-11-10
CN103037876B (zh) 2015-04-01
DK2626076T3 (en) 2016-09-19
RU2016129186A3 (pt) 2019-11-21
UA111715C2 (uk) 2016-06-10
ITMI20100375A1 (it) 2011-09-09
EP2544698B1 (en) 2016-05-04
JP2013521335A (ja) 2013-06-10
CN104800247A (zh) 2015-07-29
RU2605293C2 (ru) 2016-12-20
US20130149342A1 (en) 2013-06-13
ZA201207377B (en) 2015-04-29
RU2016129186A (ru) 2018-12-10
PL2544698T3 (pl) 2017-08-31
ES2603629T3 (es) 2017-02-28
CN103037876A (zh) 2013-04-10
WO2011110918A1 (en) 2011-09-15
CA2792343C (en) 2019-04-02
US20170071989A1 (en) 2017-03-16
HUE029245T2 (en) 2017-02-28
HUE030888T2 (en) 2017-06-28
EP2626076B1 (en) 2016-08-24
JP5931754B2 (ja) 2016-06-08
AU2011225798A1 (en) 2012-10-04
AU2011225798B2 (en) 2017-02-02
DK2544698T3 (en) 2016-07-04
BR112012022755B1 (pt) 2021-03-02
EP2544698A1 (en) 2013-01-16
PT2544698T (pt) 2016-07-15
CA2792343A1 (en) 2011-09-15
US20150017142A1 (en) 2015-01-15
RU2712751C2 (ru) 2020-01-31
US8734783B2 (en) 2014-05-27
RU2712751C9 (ru) 2020-04-28
KR101872946B1 (ko) 2018-06-29
US9498503B2 (en) 2016-11-22
ES2581803T3 (es) 2016-09-07
PL2626076T3 (pl) 2017-08-31
JP2016128502A (ja) 2016-07-14
ZA201409369B (en) 2015-09-30
RU2012140052A (ru) 2014-04-20
EP2626076A1 (en) 2013-08-14
KR20130018758A (ko) 2013-02-25
IT1398553B1 (it) 2013-03-01

Similar Documents

Publication Publication Date Title
BR112012022755A2 (pt) composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos
PH12016501512B1 (en) Treatment for resistant acne
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
BR112014026740A8 (pt) anticorpo, composição, método para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo
IN2015DN02634A (pt)
CL2011002818A1 (es) Composicion de leche para el crecimiento que comprende microorganismos probioticos; uso de dicha composicion para preparar medicamento util para prevenir o tratar trastornos inflamatorios.
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
UY32571A (es) Compuestos derivados de pirazol amida
BR112016012870A8 (pt) composições e métodos para melhorar a produção de alface
MX2013008547A (es) Composicion efervescente en forma solida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales.
MX2018009553A (es) Metodos de seleccion.
BR112016025792A2 (pt) meios e processos para tratamento de cmv
MX349886B (es) Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas.
BR112013010881A2 (pt) preparações de bebida de iogurte contendo micro-organismos probióticos não replicantes
BR112015013349A2 (pt) trieptanoína para o tratamento de deficiência de transportador de glicose 1
MX347570B (es) Compuestos triciclicos, composiciones que los comprenden y usos de los mismos.
BR112016023754A2 (pt) ?uso de lactobacillus paracasei para promover recuperação da diversidade da microbiota intestinal após disbiose?
CL2013001314A1 (es) Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
MX2010007810A (es) Coposicion que contiene capsicum para tratar un trastorno de la piel.
MX2014012164A (es) Composiciones a base de probioticos y un complejo de polen de abejas/arcilla, su preparacion y sus usos en nutricion y en terapeutica.
MX360411B (es) Uso de tiosulfato para potenciar el efecto anti-patogenico de los lactobacilos.
CL2013001313A1 (es) Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales
IN2014DN05865A (pt)
BR112014030406A8 (pt) combinação de canabidiol fitocanabinoide com hipotermia terapêutica, e, uso de uma combinação

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: PROBIOTICAL S.P.A. (IT)

B25C Requirement related to requested transfer of rights

Owner name: PROBIOTICAL S.P.A. (IT)

B25B Requested transfer of rights rejected

Owner name: PROBIOTICAL S.P.A. (IT)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/03/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.